You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 16, 2018

Vietnam Considers Law on Preventing and Combatting Harmful Effects of Alcohol and Beer

Subscribe to Updates

On April 13, 2018, the Ministry of Health (MOH) of Vietnam and the World Health Organization held a conference to introduce the main contents of the Draft Law on Preventing and Combatting Harmful Effects of Alcohol and Beer (the “Draft Law”). The Draft Law contains six chapters with 22 articles and is aimed at preventing and reducing harmful effects from alcohol and beer. The provisions introduce various measures geared toward reducing sales and controlling the production and quality of alcohol and beer supplied to the public.

One of the proposed measures to reduce alcohol and beer sales includes reducing the hours during which alcohol and beer may be sold. In this regard, the Draft Law proposes three possible measures: (1) limiting beer and alcohol sales from 11 a.m. to 2 p.m. and 5 p.m. to 10 p.m.; (2) limiting sales from 6 a.m. to 10 p.m.; or (3) limiting sales based on a phase-in to be set by the government. It is possible that special areas, such as tourist areas, recreation areas, and airports, could be exempt from such restrictions.

The Draft Law also proposes restrictions on promotions and advertising of alcohol and beer. For example, direct promotions to consumers may be prohibited, and giving beer and alcohol as prizes in contests may also be prohibited. Advertisements for certain products or advertisements in certain forms may also be prohibited or restricted to certain hours. Additionally, restrictions may be placed on depictions of drinking alcohol and beer in movies and on TV.

Some provisions in the Draft Law are geared toward regulating the density of establishments where beer and alcohol are sold within an area—for example, there may be a minimum distance required between sales establishments, such as at least 500 meters. Other regulations in the Draft Law pertain to the management of home-brewed spirits.

It is expected that the Draft Law will be submitted to the National Assembly for debate in October 2018. The Draft Law is expected to receive great interest in the public comment periods, and may be further adjusted.

Related Professionals

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

September 5, 2019
On Friday August 30, 2019, a Notification of the Thai Ministry of Public Health (“MOPH Notification”) was published in the Government Gazette. The MOPH Notification went into effect on August 31, 2019, one day after its publication.This MOPH Notification outlines another Thai Government initiative in connection with the free cannabis policy, this time carving out further aspects of marijuana and hemp use from the stringent regulations under the Narcotics Act.
Read More
September 4, 2019
The 2019 edition of Thomson Reuters’ Practical Law Life Sciences Global Guide  has been released, with its Pharmaceutical Intellectual Property and Competition Law in Cambodia chapter written by practitioners from Tilleke & Gibbins’ Phnom Penh office.The guide is a Q&A-style overview of the regulatory frameworks for the life sciences industries across jurisdictions worldwide. This chapter on pharmaceutical IP and competition law in Cambodia addresses the following issues in the country’s legal landscape for life sciences:
Read More
September 3, 2019
On February 19, 2019, by amending the Narcotics Act B.E. 2522, Thailand caught the cannabis industry by surprise and became the first Asia-Pacific country to legalize medicinal cannabis. While hemp had been approved for use in industry since 2018 (see here), the amendment of the Narcotics Act B.E. 2522, providing for a Thai FDA registration pathway for medicinal cannabis, was largely unexpected.   
Read More
May 21, 2019
On April 16, 2019, the Drug Act (No. 6) B.E. 2562 was published in the Government Gazette, amending the previous drug registration processes, clinical research processes, and fee schedules. The changes will apply to all pending applications and those filed from October 13, 2019 onward.New Requirements for RegistrationAn additional requirement has been added to the registration process for new drugs. Along with the drug registration dossier, the following documents must now be submitted for each drug classification:
Read More